Body Protection Compound — 5mg/vial
$102.30 AUD
HPLC tested, 99%+ purity. Third-party verified.
💧 Need BAC water? 30mL bacteriostatic water available — $21.90 ($13 less than AU competitors). Add to your order.
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. First identified in the 1990s by Dr Predrag Sikiric at the University of Zagreb, it has since become one of the most extensively studied regenerative peptides in preclinical science.
This 15 amino-acid peptide demonstrates remarkable effects on tissue repair, cytoprotection, and systemic healing. Its unique mechanism of action — activating the FAK-paxillin signalling pathway — governs cellular migration and promotes angiogenesis, making it a compound of significant interest across multiple research disciplines.
"FOR RESEARCH USE ONLY. This information is provided for scientific and educational purposes only. It does not constitute medical advice or a recommendation for human use."
| Compound | BPC-157 |
| Form | Lyophilized powder |
| Dosage | 5mg/vial |
| Purity | 99%+ (HPLC verified) |
| Testing | Third-party HPLC + MS |
| Storage | 2-8°C (refrigerated) |
| Origin | GMP facility |
BPC-157 acts primarily through upregulation of the FAK-paxillin signalling pathway, which governs cellular migration and tendon fibroblast outgrowth. It also stimulates VEGF (vascular endothelial growth factor) expression to promote angiogenesis and neo-vascularisation at injury sites.
Additional mechanisms include growth hormone receptor upregulation in skeletal muscle and modulation of the nitric oxide (NO) system via both NO-independent and NO-dependent pathways. This multi-pathway activity profile explains the compound's broad research interest across regenerative biology.
Every batch independently tested via HPLC and Mass Spectrometry. COAs published on site.
Based in Australia with express shipping nationwide. Discreet, temperature-controlled packaging.
Every batch independently tested via HPLC and Mass Spectrometry. COAs published on site. 99%+ purity guaranteed.
Preclinical models typically use 2–10 µg/kg/day. Common research protocols range from 250–500 mcg per injection administered subcutaneously or intramuscularly, often twice daily. Always follow your institution's ethical guidelines and IACUC-approved protocols.
Reconstitute using bacteriostatic water or sterile water for injection. Gently swirl — do not shake. Once reconstituted, refrigerate at 2–8°C and use within 7–14 days for best stability.
Yes, BPC-157 is legal to purchase for legitimate research purposes in Australia. It is not a scheduled substance when intended for research use only. All sales are for research use only — not for human or veterinary consumption.
Every batch is sent to an independent third-party laboratory for HPLC (High-Performance Liquid Chromatography) and Mass Spectrometry analysis. Results confirming 99%+ purity are published as Certificates of Analysis on our site.
Enter your email and we'll alert you the moment it's back in stock.